Rangesh Abinand's Form 4 filing
Tecogen Inc. (TGEN) · filed Sep 1, 2023
- Accession no.
- 0001537435-23-000104
- Filed
- Sep 1, 2023
- Trade date
- Aug 15-30, 2023
- Filing delay
- 17 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $1.02K. It was filed 17 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rangesh AbinandCIK 0001917503 | Director, Officer (Chief Executive Officer), Other: Chief Financial Officer |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2023 | Common Stock | PPurchaseAcquired | +1 | $0.95 | +$0.95 | 9,301 | Direct | |
| Aug 23, 2023 | Common Stock | PPurchaseAcquired | +200 | $1.02 | +$204 | 9,501 | Direct | |
| Aug 30, 2023 | Common Stock | PPurchaseAcquired | +800 | $1.02 | +$816 | 10,301 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.